Last reviewed · How we verify

NCT05700682: MRI

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

Recruiting now Last updated 7 August 2025
What this trial tests

trial testing Shoulder/Hip/Knee Embolization with Embozene Microspheres in Osteoarthritis, Knee in 120 participants. Currently enrolling.

Timeline
15 July 2023
Primary endpoint
1 March 2026
1 August 2026

Quick facts

Lead sponsorPalo Alto Veterans Institute for Research
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date15 July 2023
Primary completion1 March 2026
Estimated completion1 August 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Palo Alto Veterans Institute for Research

Who can join

Adults 25 to 80, any sex, with Osteoarthritis, Knee or Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this work the investigators will study the relationship between chronic musculoskeletal pain and abnormal blood flow (neovascularity) around the shoulder, hip and knee. Veterans with as history of chronic shoulder, hip or knee pain and mild/moderate joint degenerative changes will be potential study subjects. Blood flow around joints will be evaluated using perfusion magnetic resonance imaging (MRI). Participants with demonstrably abnormal blood flow around their painful joint will be eligible for enrollment in a pilot study of joint embolization to treat their pain. Participants who choose to not undergo treatment will be re-assessed with MRI after one year to characterize the natural history of joint neovascularity and its relationship to pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Palo Alto Veterans Institute for Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05700682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing